Breaking News Instant updates and real-time market news.

ADI

Analog Devices

$89.12

3.57 (4.17%)

04:55
11/21/18
11/21
04:55
11/21/18
04:55

Analog Devices price target raised to $105 from $100 at B. Riley FBR

B. Riley FBR analyst Craig Ellis raised his price target for Analog Devices to $105 saying the company's "solid" quarter ad "above-peer" guidance shows the company's favorable portfolio positioning. The analyst keeps a Buy rating on the shares.

  • 26

    Nov

ADI Analog Devices
$89.12

3.57 (4.17%)

10/18/18
10/18/18
DOWNGRADE

Sell
Analog Devices, Maxim Integrated downgraded to Sell at Goldman Sachs
As previously reported, Goldman Sachs analyst Toshiya Hari downgraded Analog Devices (ADI) and Maxim Integrated (MXIM), both to Sell from Neutral. He cut his Industrial and Automotive revenue estimates for Maxim and sees downside to estimates, leading Hari to lower his price target on the shares to $47 from $56. He also expressed his "guarded view" on the Analog cycle by also reducing Automotive and Industrial estimates for Analog Devices and lowering his price target on its shares to f $81 from $106.
10/18/18
10/18/18
UPGRADE
Target $94

Neutral
Texas Instruments upgraded to Neutral on defensive nature at Goldman Sachs
As previously reported, Goldman Sachs analyst Toshiya Hari upgraded Texas Instruments (TXN) to Neutral from Sell, stating that while he remains guarded on the overall Analog cycle, the stock has proven in the past to be more defensive during industry downturns. While noting that Texas Instruments has historically outperformed Analog Devices (ADI) and Maxim Integrated (MXIM) during periods of decelerating analog industry revenue growth, Hari also this morning downgraded both of the latter two stocks to Sell. Hari also lowered his calendar 2019 and 2020 revenue estimates for TI by 8% and 10%, respectively, and cut his price target on the shares to $94 from $107.
10/18/18
GSCO
10/18/18
UPGRADE
Target $305
GSCO
Conviction Buy
Semi re-stack puts Nvidia on Goldman Conviction List with 25% upside
Goldman Sachs analyst Toshiya Hari this morning added Buy-rated Nvidia (NVDA) to his firm's Conviction List while lowering his price target for the shares to $305 from $324. The stock in morning trading is up 85c to $243.91. Following a "significant correction" in the stock's valuation, the analyst expects Nvidia's "idiosyncratic growth drivers," like its product cycle in Gaming and potential share gains in Data Center, to drive share outperformance. While lowering his January quarter earnings per share estimate to $1.90 from $2.28 to reflect potential volume and average selling price weakness in the Gaming business, Hari recommends investors to buy the stock at current levels with his long-term thesis intact. He sees potential upside of 25% for Nvidia shares. Positive earnings revisions post the Q3 earnings report should serve as a positive catalyst for the stock, contends the analyst. Putting Nvidia on his firm's Conviction List was part of Hari's rating re-stack in the Semiconductors sector. Also this morning, the analyst downgraded both Analog Devices (ADI) and Maxim Integrated Products (MXIM) to Sell from Neutral, downgraded Teradyne (TER) to Neutral from Buy, upgraded both Keysight Technologies (KEYS) and NXP Semiconductors (NXPI) to Buy from Neutral, and upgraded Texas Instruments (TXN) to Neutral from Sell. Hari also maintained a Conviction List Buy rating on Xilinx (XLNX) and a Sell rating on Intel (INTC).
11/20/18
SRCH
11/20/18
UPGRADE
SRCH
Buy
Analog Devices upgraded to Buy from Hold at Summit Insights

TODAY'S FREE FLY STORIES

HQY

HealthEquity

$82.92

0.82 (1.00%)

16:12
03/18/19
03/18
16:12
03/18/19
16:12
Hot Stocks
HealthEquity reports Q4 EPS 27c, consensus 22c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 19

    Mar

  • 21

    Mar

  • 17

    Apr

RMAX

RE/MAX Holdings

$39.09

1.07 (2.81%)

, RDFN

Redfin

$18.50

0.04 (0.22%)

16:12
03/18/19
03/18
16:12
03/18/19
16:12
Hot Stocks
RE/MAX Holdings, Redfin announce exclusive referral relationship »

RE/MAX Holdings (RMAX)…

RMAX

RE/MAX Holdings

$39.09

1.07 (2.81%)

RDFN

Redfin

$18.50

0.04 (0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 26

    Mar

  • 27

    Mar

FWRD

Forward Air

$64.27

0.66 (1.04%)

16:11
03/18/19
03/18
16:11
03/18/19
16:11
Hot Stocks
Forward Air to acquire FSA Logistix »

Forward Air Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFSW

PFSweb

$6.35

0.27 (4.44%)

16:11
03/18/19
03/18
16:11
03/18/19
16:11
Earnings
PFSweb reports Q4 EPS 17c, may not compare to consensus 24c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 27

    Mar

  • 28

    Mar

ICAD

iCAD

$4.44

-0.02 (-0.45%)

16:10
03/18/19
03/18
16:10
03/18/19
16:10
Earnings
iCAD reports Q4 EPS (20c), two-estimate consensus (10c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

VERU

Veru

$1.44

-0.05 (-3.36%)

16:10
03/18/19
03/18
16:10
03/18/19
16:10
Initiation
Veru initiated  »

Veru initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 26

    Mar

CYAD

Celyad

$21.35

(0.00%)

16:10
03/18/19
03/18
16:10
03/18/19
16:10
Hot Stocks
Celyad provides update on CYAD-01 at R&D Day »

Celyad presented at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 19

    Mar

  • 20

    Mar

  • 04

    Apr

  • 09

    Apr

CRBP

Corbus Pharmaceuticals

$6.90

0.18 (2.68%)

16:10
03/18/19
03/18
16:10
03/18/19
16:10
Initiation
Corbus Pharmaceuticals initiated  »

Corbus Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

TACO

Del Taco

$10.59

0.46 (4.54%)

16:09
03/18/19
03/18
16:09
03/18/19
16:09
Earnings
Del Taco sees FY19 adjusted EPS 47c-52c, consensus 58c »

Sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

AKBA

Akebia

$8.19

0.01 (0.12%)

16:09
03/18/19
03/18
16:09
03/18/19
16:09
Earnings
Akebia reports Q4 revenue $59.9M, consensus $73.67M. »

Reports Q4 net loss…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

TACO

Del Taco

$10.58

0.45 (4.44%)

16:08
03/18/19
03/18
16:08
03/18/19
16:08
Earnings
Del Taco reports Q4 adjusted EPS 18c, consensus 19c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

TORC

ResTORbio

$8.96

0.26 (2.99%)

16:08
03/18/19
03/18
16:08
03/18/19
16:08
Hot Stocks
ResTORbio reports Q4 EPS (21c), consensus (34c) »

Cash, cash equivalents…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CUI

CUI Global

$1.41

0.065 (4.85%)

16:07
03/18/19
03/18
16:07
03/18/19
16:07
Hot Stocks
CUI Global agrees to terms for approximate 20% interset in Virtual Power Systems »

The company agreed to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

ROP

Roper Technologies

$331.34

5.2 (1.59%)

16:07
03/18/19
03/18
16:07
03/18/19
16:07
Hot Stocks
Roper Technologies to acquire Foundry »

Roper Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEAM

Atlassian

$111.01

0.74 (0.67%)

16:06
03/18/19
03/18
16:06
03/18/19
16:06
Hot Stocks
Atlassian to acquire AgileCraft for $166M »

Atlassian Corp announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLRY

Tilray

$72.33

-0.2 (-0.28%)

16:06
03/18/19
03/18
16:06
03/18/19
16:06
Earnings
Tilray reports Q4 EPS (33c), consensus (12c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

CUI

CUI Global

$1.41

0.065 (4.85%)

16:06
03/18/19
03/18
16:06
03/18/19
16:06
Earnings
CUI Global reports Q4 EPS (27c), consensus (6c) »

Reports Q4 revenue $27M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

CYTK

Cytokinetics

$8.22

0.43 (5.52%)

, AMGN

Amgen

$191.69

0.58 (0.30%)

16:05
03/18/19
03/18
16:05
03/18/19
16:05
Hot Stocks
Cytokinetics COSMIC-HF study meets primary pharmacokinetic objective »

Cytokinetics (CYTK)…

CYTK

Cytokinetics

$8.22

0.43 (5.52%)

AMGN

Amgen

$191.69

0.58 (0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNI

Canadian National

$88.56

0.94 (1.07%)

16:05
03/18/19
03/18
16:05
03/18/19
16:05
Hot Stocks
CN investing more than $245M to strengthen Saskatchewan rail infrastructure »

CN it plans to invest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Apr

GS

Goldman Sachs

$202.36

4.09 (2.06%)

16:04
03/18/19
03/18
16:04
03/18/19
16:04
Periodicals
Goldman intends to interview two diverse candidates for any open job, WSJ says »

Goldman Sachs managers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVTI

Covenant Transportation

$21.46

-0.37 (-1.69%)

16:04
03/18/19
03/18
16:04
03/18/19
16:04
Earnings
Covenant Transportation sees Q1 EPS 18c-26c, consensus 36c »

Covenant CEO David Parker…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAM

Boston Beer

$311.83

5.025 (1.64%)

, UBER

Uber

$0.00

(0.00%)

16:03
03/18/19
03/18
16:03
03/18/19
16:03
Hot Stocks
Boston Beer names Meghan Joyce to Board of Directors »

The Boston Beer Company…

SAM

Boston Beer

$311.83

5.025 (1.64%)

UBER

Uber

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

AQB

AquaBounty

$2.79

-0.06 (-2.11%)

16:01
03/18/19
03/18
16:01
03/18/19
16:01
Syndicate
AquaBounty files to sell common stock, no amount given »

H.C. Wainwright & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVTI

Covenant Transportation

$21.46

-0.37 (-1.69%)

16:00
03/18/19
03/18
16:00
03/18/19
16:00
Hot Stocks
Breaking Hot Stocks news story on Covenant Transportation »

Covenant Transportation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QCOM

Qualcomm

$56.73

0.13 (0.23%)

, INTC

Intel

$54.04

-0.285 (-0.52%)

15:57
03/18/19
03/18
15:57
03/18/19
15:57
Periodicals
USPTO agrees to review of Qualcomm patent requested by Intel, Bloomberg says »

The USPTO's U.S.…

QCOM

Qualcomm

$56.73

0.13 (0.23%)

INTC

Intel

$54.04

-0.285 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 25

    Apr

  • 01

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.